EMA publishes its work programme for 2014
19 March 2014 | By The European Medicines Agency
The European Medicines Agency has published its work programme for 2014...
List view / Grid view
News
Sanofi Pasteur allies with SK Chemical Co. of South Korea on pneumococcal conjugate vaccine
19 March 2014 | By Sanofi
A long-term strategic business collaboration to co-develop and commercialize an innovative vaccine against pneumococcal infection to address global public-health needs...
Pfizer launches 2013 integrated annual review
19 March 2014 | By Pfizer Inc
Pfizer Inc. announced the launch of its fourth integrated annual review, which summarizes the company’s 2013 financial, environmental and social responsibility performance...
Astellas Pharma and Daiichi Sankyo form compound library sharing partnership
19 March 2014 | By Daiichi Sankyo Company
Astellas Pharma Inc. and Daiichi Sankyo Company, Limited announced the companies would form a compound library sharing partnership for approximately 400,000 selected compounds...
Biogen Idec receives notification of PDUFA date extension for PLEGRIDY™
18 March 2014 | By Biogen Idec
Biogen Idec announced that the U.S. Food and Drug Administration has extended the initial Prescription Drug User Fee Act date for its review of the Biologics License Application for marketing approval of PLEGRIDY...
First patients enrolled into European Phase III programme for potential first in class oral treatment for anaemia associated with chronic kidney disease
18 March 2014 | By Astellas
Roxadustat could change treatment of anaemia associated with CKD and remove the need for multiple injections...
Lundbeck and Otsuka initiate European launch of Abilify Maintena®, a once-monthly formulation for the treatment of schizophrenia
18 March 2014 | By Lundbeck
Denmark is the first country in Europe where Abilify Maintena® is fully reimbursed and accessible to people diagnosed with schizophrenia...
Five Prime Therapeutics and Bristol-Myers Squibb sign collaboration agreement to discover novel immuno-oncology therapies
17 March 2014 | By Bristol-Myers Squibb
Five Prime Therapeutics, Inc. and Bristol-Myers Squibb Company announced that they have signed a collaboration agreement for the discovery, development and commercialization of immuno-oncology therapies...
Amgen announces positive top-line results from Phase 3 TESLA trial of evolocumab in patients with homozygous familial hypercholesterolemia
17 March 2014 | By Amgen
Study meets primary endpoint of LDL cholesterol reduction First phase 3 data of a pcsk9 inhibitor in patients with homozygous familial hypercholesterolemia - a rare and serious disease...
GSK and Theravance announce positive results from studies comparing ANORO™ ELLIPTA™ with SERETIDE® DISKUS® and ADVAIR® DISKUS®
14 March 2014 | By GlaxoSmithKline
GlaxoSmithKline plc and Theravance, Inc. announced positive results from three phase III studies...
Novo Nordisk invests 550 million Danish kroner in new purification pilot plant in Denmark
14 March 2014 | By Novo Nordisk
Novo Nordisk is increasing its drug development capacity by investing 550 million Danish kroner in a new research and development facility in Bagsværd, Denmark...
Patient recruitment completes in landmark RELVAR®/ BREO® ELLIPTA® study to understand mortality and morbidITy (SUMMIT) in COPD
14 March 2014 | By GlaxoSmithKline
GlaxoSmithKline plc and Theravance, Inc. announced that recruitment of patients into the “Study to Understand Mortality and MorbidITy”, known as SUMMIT, has completed enrolment...
Type 2 Diabetes: New poll of more than 700 Latin American physicians provides insights into complexity and challenges
14 March 2014 | By Boehringer Ingelheim
More than 73 percent of physicians surveyed said the complexity of Type 2 Diabetes is underestimated...
FDA Advisory committee unanimously recommends Roche’s HPV Test as primary screening tool for detection of women at high risk for cervical cancer
13 March 2014 | By Roche
Roche announced that the U.S. Food and Drug Administration Microbiology Devices Panel of the Medical Devices Advisory Committee recommended unanimously that the benefits of the cobas HPV Test...
Novartis Bexsero® meningitis B vaccine receives clinical recommendation for use in infants and adolescents in Australia
13 March 2014 | By Novartis
Novartis has announced that Australia has joined the growing number of countries where following licensure, Bexsero® has received a clinical recommendation...
